2016


To access this material please log in or register

Register Authorize
2016/№3

A clinical case of using a fixed-dose combination of enalapril and nitrendipine in an elderly female patient with arterial hypertension

Kardangusheva A. M.
Federal State Budgetary Educational Institution of Higher Education, “Kh. M. Berbekov Kabardino-Balkarian State University”, Chernyshevskogo 173, Nalchik 360004

Keywords: hyperpiesis, treatment, elderly age

DOI: 10.18087/rhj.2016.3.2212

The author provided a case report of an elderly female patient with arterial hypertension and high risk of cardiovascular complications.
  1. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CL. Selected major risk factors and global and regional burden of dise­ase. Lancet. 2002 Nov 2;360 (9343):1347–60.
  2. AlGhatrif M, Strait JB, Morrell CH, Canepa M, Wright J, Elango P et al. Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore Longitudinal Study of Aging. Hypertension. 2013 Nov;62 (5):934–41.
  3. Ferreira I, van de Laar RJ, Prins MH, Twisk JW, Stehouwer CD. Carotid stiffness in young adults: a life-course analysis of its early determinants: the Amsterdam Growth and Health Longitudinal Study. Hypertension. 2012 Jan;59 (1):54–61.
  4. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension. 2007 Jan;49 (1):69–75.
  5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. Seventh report of Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003 Dec;42 (6):1206–52.
  6. Кобалава Ж. Д., Котовская Ю. В. Артериальная гипертония в XXI веке: достижения, проблемы, перспективы. (2‑е издание, дополненное и переработанное). – М.: «Бионика Медиа», 2015. – С 265–274 [Kobalava Zh. D., Kotovskaya Yu. V. Arterial`naya gipertoniya v XXI veke: dostizheniya, problemy`, perspektivy`. (2‑e izdanie, dopolnennoe i pererabotannoe). – M.: «Bionika Media», 2015. – S 265–274].
  7. Safar ME, Thomas F, Blacher J, Nzietchueng R, Bureau JM, Pannier B, Benetos A et al. Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol. 2006 Jan 3;47 (1):72–5.
  8. Launer LJ, Hughes T, Yu B, Masaki K, Petrovich H, Ross GW, White LR. Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program / Honolulu Asia Aging Study. Hypertension. 2010 Jun;55 (6):1352–9.
  9. Шальнова С. А., Баланова Ю. А., Константинов В. В., Тимофеева Т. Н., Иванов В. М., Капустина А. В., Деев А. Д. Артери­альная гипертония: распространенность, осведомленность, прием антигипертензивных препаратов и эффективность лечения среди населения Российской Федерации. Российский кардиологический журнал. 2006;4:45–50 [Shal`nova S. A., Balanova Yu. A., Konstantinov V. V., Timofeeva T. N., Ivanov V. M., Kapustina A. V., Deev A. D. Arterial`naya gipertoniya: rasprostranennost`, osvedomlennost`, priem antigipertenzivny`x preparatov i e`ffektivnost` lecheniya sredi naseleniya Rossijskoj Federaczii. Rossijskij kardiologicheskij zhurnal. 2006;4:45–50].
  10. Fletcher A, Bulpitt C. Epidemiology of hypertension in the elderly. J Hypertens. 1994 Sep;12 (Suppl 6):S3–5.
  11. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M et al. 2013 ESH / ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of hypertension (ESH) and of the European Society of cardiology (ESC). J Hypertens. 2013 Jul;31 (7):1281–357.
  12. Аронов Д. М., Арабидзе Г. Г., Ахмеджанов Н. М., Балахонова Т. В., Бойцов С. А., Бубнова М. Г. и др. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации V пересмотр. 2012:­1–29. Доступно на: http://noatero.ru / sites / default / files / pocket_guidelines.pdf [Aronov D. M., Arabidze G. G., Axmedzhanov N. M., Balaxonova T. V., Bojczov S. A., Bubnova M. G. i dr. Diagnostika i korrekcziya narushenij lipidnogo obmena s czel`yu profilaktiki i lecheniya ateroskleroza. Rossijskie rekomendaczii V peresmotr. 2012:­1–29. Dostupno na: http://noatero.ru / sites / default / files / pocket_guidelines.pdf]
  13. Go AS, Bauman MA, Coleman King SM, Fonarow GC, Lawrence W, Williams KA et al. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension. 2014 Apr;63 (4):878–85.
  14. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH et al. Randomised double-blind comparison of placebo and active treatment or older patients with isolated systolic hypertension. Lancet. 1997 Sep 13;350 (9080):757–64.
  15. Thijs L, Staessen JA, Beleva S, Birkenhager WH, Bulpitt CJ, Celis H et al. How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2). Curr Control Trials Cardiovasc Med. 2001 Oct 18;2 (6):298–306.
  16. Tuomilehto J, Rastenyte D, Birkenhager WH, Thijs L, Antikainen R, Bulpitt CJ et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med. 1999 Mar 4;340 (9):677–84.
  17. De Leeuw PW, Thijs L, Birkenhager WH, Voyaki SM, Efstratopoulos AD, Fagard RH et al. Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial. J Am Soc Nephrol. 2002 Sep;13 (9):2213–22.
  18. Thijs L, Richart T, de Leeuw PW, Kuznetsova T, Grodzicki T, Kawecka-Jaszcz K et al. Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the Systolic Hypertension in Europe trial. J Hypertens. 2010 Apr;28 (4):865–74.
  19. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998 Oct 24;352 (9137):1347–51.
  20. De la Sierra A, Roca-Cusachs A, Redὁn J, Marin R, Luque M, de la Figuera M et al. Effectiveness and tolerability of fixed-dose combination enalapril plus nitrendipine in hypertensive patients: results of the 3‑month observational, post-marketing, multicentre, prospective CENIT study. Clin Drug Investig. 2009;29 (7):459–69.
  21. Trenkwalder P. The Efficacy and tolerability of an antihypertensive fixed combination of enalapril and nitrendipine. Perfusion. 2004;7:394–9.
  22. Леонова М. В., Белоусов Ю. Б., Штейнберг Л. Л., Галицкий А. А., Белоусов Д. Ю. Фармакоэпидемиология артериальной гипертонии в России (по результатам фармакоэпидемиологического исследования ПИФАГОР III). Российский кардиологический журнал. 2011;2 (88):9–16 [Leonova M. V., Belousov Yu. B., Shtejnberg L. L., Galiczkij A. A., Belousov D. Yu. Farmakoe`pi­demiologiya arterial`noj gipertonii v Rossii (po rezul`tatam farmakoe`pidemiologicheskogo issledovaniya PIFAGOR III). Rossijskij kardiologicheskij zhurnal. 2011;2 (88):9–16].
Kardangusheva A. M. A clinical case of using a fixed-dose combination of enalapril and nitrendipine in an elderly female patient with arterial hypertension. Russian Heart Journal. 2016;15 (3):210–216

To access this material please log in or register

Register Authorize
Ru En